Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Mr Gurdeep S. Mannu who has been awarded a five-year Cancer Research UK Clinician Scientist Fellowship.

Gurdeep Mannu

This prestigious fellowship provides support for excellent individuals to develop a clinical academic research career through a period of postdoctoral training. 

Based jointly between the Nuffield Department of Surgical Sciences (NDS) and the Nuffield Department of Population Health (NDPH), the award will allow Mr Mannu to start his independent research group – Surgical Epidemiology Group (SEG) – which is interested in translating epidemiological research to help in the care of surgical patients diagnosed with breast cancer.   

Breast cancer is the commonest cancer in women in the UK and ductal carcinoma in situ (DCIS) is its commonest pre-invasive form.

Mr Mannu’s research uses large datasets from routine data sources, observational studies, and data from randomised trials to better understand the epidemiology and optimal treatment of breast cancer.

The results of his research will help to identify ways to improve the surveillance of women after pre-invasive breast cancer, help translate existing research into the clinic, and streamline future randomised trials to improve treatments for future breast cancer patients. 

His research will also provide doctors and patients with improved information on the likely outcomes from various treatments to help in treatment decision-making.

Commenting on his success, Mr Mannu said: “I am delighted to receive this fellowship and am looking forward to undertaking research that will make a difference to women diagnosed with breast cancer.”

Similar stories

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.

NDS SITU host first ever Surgical Trials Showcase

The first ever showcase of the Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences (NDS SITU) was hosted on Monday 23 January 2023 at the Richard Doll Building on Old Road Campus, Oxford, and also online.

EndoNET randomises first patient of 2023

A trial investigating how effective endocrine treatment is, prior to surgery in post-menopausal women with breast cancer, has randomised its first patient of the year.

Blog posts

Marathon challenge for Prostate Cancer UK

Runners of all abilities started 2023 by challenging themselves to run 26.2 miles across January to fundraise for Prostate Cancer UK as part of the charity’s Run the Month: Marathon Edition.

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.